Features of violations in a cell-like link of the immune system at different types neurofibromatosis

Authors

  • V. I. Tsymbaliuk Romodanov Neurosurgery Institute, Kiev, Ukraine
  • N. I. Lisyany Romodanov Neurosurgery Institute, Kiev, Ukraine
  • M. V. Kvasnitsky I. Horbachevsky Ternopil State Medical University, Ternopil, Ukraine

Keywords:

нейрофіброматоз, імунологія.

Abstract

The cellular immunity in 41 patients with neurofibromatosis is investigated. Among them neurofibromatosis 1 — 32 patients, neurofibromatosis 2 — 9 patients. Suppression of the natural killer’s activity and antibody-dependent cytotoxicity of mononuclears, disbalance in main subpopulations of lymphocytes — augmentation of Т-suppressors level and B-lymphocytes, decreasing of NK-cells level and normal level of Т-helpers — are revealed. Dependence of changes on type of neurofibromatosis is also determined.

References

1. Бережная Н.М., Чехун В.Ф. Система интерлейкинов и paк. — 2000. — 224 c.

2. Зозуля Ю.П., Лісяний M.I. Нейрогенний імуннодефіцит при вогнищевих ураженнях головного мозку та його клінічне значення // Журн.АМН України. — 1998. — №1. — C.44—63.

3. Лисяный Н.И., Маркова О.В., Главацкий А.Я. Количественные и функциональные характеристики NK-клеток, выделенных из опухолей, как показатель для иммунотерапии глиом головного мозга // В кн.: Иммунотерапия при лечении злокачественннх опухолей. — К.,1998. — С.75—77.

4. Лисяный Н.И., Маркова О.В., Ромоданов С.А. Чувствительность клеток человека различной степени анаплазии к лизису опосредованному естественными киллерами // Бюллетень зкспер.биол.и мед. — 1991. — №8. — С.190—191.

5. Мельников О.Ф., Заяц Т.А. Сравнение радиоизотопного и спектрофотометрического методов определения цитотоксичности клеток // Лаб. диагностика. — 1999. — №1. — C.43—45.

6. Новиков Д.К. Противоопухолевые реакции лейкоцитов. — 1988. — 266 с.

7. Чечнев С.Б. Фенотипическая и функциональная гетерогенность циркулирующего пула естественных киллеров // Иммунология. — 1999. — №4. — C.24—27.

8. Ars Е. et al. Mutations affecting mRNA splicing are the most common molecular defects іп patients with neurofibromatosis typel // Hum. Мої. Genet.- 2000. — V.9, N.2. — P.237—244.

9. Crawford A.H., Schorry E.K. Neurofibromatosis in children: the role of the orthopaedist .// J. Aimn. Acad. Orthop. Surg. — 1999. — V.7, N.4. — P.217—230.

10. Gerosa P.L., Vai С., Bizzozero L. et. al. Local immune response in neurofibromatosis typel andtype2 // Minerva Med. — 1993. — V.84, N.1—2. — P.23—31.

11. Kilic S., Tezcan I., Sanal 0., Ersoy F. Conunon variable immunodeficiency in a patient with neurofibromatosis // Pediatr Int. — 2001. — V.43, N.6. — P.691—693.

12. Park K.C. et al. Identification of two novel frame shift mutations of the NF1 gene m Korean patients with neurofibromatosis type 1 // J. Korean Med. Set. — 2000. — V.15, N.5. —P.542—544.

13. Roukau G.A. et al. Alteration m a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type2 //’ Nature. —1993. — V.363. — P.515—521.

14. Trofatter J. A. et al. A novel moesin-, ezrin-, radixin- like gene is a candidate for the neurofibromatosis 2 tumors supressor // Cell. — 1993. — V.72. — P.791—800.

Downloads

How to Cite

Tsymbaliuk, V. I., Lisyany, N. I., & Kvasnitsky, M. V. Features of violations in a cell-like link of the immune system at different types neurofibromatosis. Ukrainian Neurosurgical Journal, (3), 72–75. Retrieved from https://theunj.org/article/view/92723

Issue

No. 3 (2002)

Section

Original articles

License

Copyright (c) 2002 V. I. Tsymbaliuk, N. I. Lisyany, M. V. Kvasnitsky

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Ukrainian Neurosurgical Journal abides by the  CREATIVE COMMONS copyright rights and permissions for open access journals.

Authors, who are published in this Journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.

2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.